Peritoneal Dialysis-associated Peritonitis Clinical Trial
Official title:
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold)
According to the requirements of the "Technical Guidelines for Clinical Trials of In Vitro Diagnostic Reagents", the first registered product (hereinafter referred to as the assessment reagent) - Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) was tested in clinical institutions. ) for clinical validation trials. Prove that the clinical performance of the assessment reagent meets the requirements of the intended use.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03264625 -
The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis
|
Phase 2 | |
Suspended |
NCT05300191 -
In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Device
|
||
Completed |
NCT03685747 -
Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis
|
Phase 1 | |
Recruiting |
NCT03046511 -
Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.
|
Phase 3 | |
Recruiting |
NCT05285436 -
A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis
|
N/A | |
Recruiting |
NCT05860270 -
Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis
|
Phase 4 | |
Recruiting |
NCT05971537 -
Clinical Trial on Antibiotic-Lock in Tenckhoff Catheter for Relasping and Repeat Peritonitis
|
Phase 4 | |
Completed |
NCT01293799 -
Prevention of Peritonitis in Peritoneal Dialysis
|
N/A | |
Withdrawn |
NCT03675854 -
Defining the Optimal Duration of Treatment for "Low-Risk" Peritoneal Dialysis-Related Peritonitis
|
Phase 4 | |
Terminated |
NCT00801775 -
Improved Diagnosis of Peritoneal Dialysis Peritonitis by Calorimetry
|
N/A | |
Completed |
NCT04515498 -
A Prospective Clinical Study of the CloudCath System During In-home Peritoneal Dialysis
|